ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983

House, Senate Committee Increase FDA Funding, Drop User Fees

August 4, 1989

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

March 23, 2001

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15

November 24, 1995

In Brief: Panel To Select Breast Committee Forom 130 Nominations; Bristol Plans Move To Princeton

December 6, 1991